Company / Revenue
Xenon Pharmaceuticals Inc. Revenue History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$15.6M
FY2017
5-year range
-
FY2016-FY2017
Trend
+763.9%
vs FY2016
Sector context
#132 of 155
Health Care
What the data says
Xenon Pharmaceuticals Inc.'s revenue of $16M is lower than 85% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
$16M in FY2017.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 155This company $15.6M Sector average $4.5B
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2017, revenue increased 763.9% year-over-year.
- Ranks #132 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $15.6M | +763.9% |
| FY2016 | $1.8M | -88.4% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026